IDEAYA Biosciences shares are trading higher after SVB Leerink initiated coverage on the stock with an Outperform rating and announced a $33 price target.
Portfolio Pulse from Benzinga Newsdesk
IDEAYA Biosciences shares are trading higher after SVB Leerink initiated coverage on the stock with an Outperform rating and a $33 price target.
August 09, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEAYA Biosciences' stock price is likely to increase in the short term due to the positive rating and price target set by SVB Leerink.
SVB Leerink, a well-known investment bank, has initiated coverage on IDEAYA Biosciences with an Outperform rating and a $33 price target. This positive outlook is likely to attract investors, driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100